Comparison of Etomidate, Propofol and Etomidate-propofol Combination in Terms of Effects on Haemodynamic Response to Intubation
NCT ID: NCT02186990
Last Updated: 2014-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
90 participants
INTERVENTIONAL
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Propofol and Ketamine on Cardiovascular Collapse During Induction for Intubation
NCT06750939
Comparison of Different Propofol Formulations
NCT01041872
A Comparison Between Propofol and Etomidate in Hysteroscopy on Effect of Postoperative Sedation and Cognitive Function in Elderly Patients
NCT02147678
Comparison of Etomidate Plus Propofol, Etomidate Alone on Induction of Anesthesia
NCT03820388
Anesthesia Induction with the Target-controlled Infusion of Propofol in High-risk Patients
NCT06535230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
propofol
etomidate-propofol
0,15 mg/kg etomidate + 1,25 mg/kg propofol
etomidate
etomidate
0,3 mg/kg
propofol-etomidate
propofol
2,5 mg/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
propofol
2,5 mg/kg
etomidate
0,3 mg/kg
etomidate-propofol
0,15 mg/kg etomidate + 1,25 mg/kg propofol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I - II status
* elective surgery
Exclusion Criteria
* pregnancy
* alcohol and drug abuse
* HT and cardiovascular disease
* BMI \> 25 kg/m2
* hypersensitivity against study drug
* sedative drug use in last month
* difficult intubation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
özgür yağan
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital
Altinordu, Ordu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Odu-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.